Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Julia E. McGuinness"'
Autor:
Katherine D. Crew, Melissa K. Accordino, Alessandro Marone, Shing M. Lee, Lauren Franks, Andreas H. Hielscher, Kevin Kalinsky, Julia E. McGuinness, Dawn L. Hershman, Mirella L. Altoe, Meghna S. Trivedi, Mariella Tejada, Hyun K. Kim
Publikováno v:
Breast Cancer Research and Treatment. 189:297-304
Diffuse optical tomography breast imaging system (DOTBIS) non-invasively measures tissue concentration of hemoglobin, which is a potential biomarker of short-term response to neoadjuvant chemotherapy. We evaluated whether DOTBIS-derived measurements
Publikováno v:
Breast Cancer Research and Treatment. 189:1-13
While checkpoint inhibitors have been approved in patients with newly metastatic PDL1-positive triple negative breast cancer, similar clinical benefit with immunotherapy alone or in combination with chemotherapy has not been observed in patients with
Autor:
Simukayi Mutasa, Julia E. McGuinness, Richard Ha, Katherine D. Crew, Jana Lee, Aishwarya Anuraj
Publikováno v:
Cancer Research. 81:PS5-21
Background: The standard of care for early-stage hormone receptor (HR)-positive breast cancer is 5-10 years of adjuvant endocrine therapy (ET), which is associated with a 50-60% relative risk reduction in breast cancer recurrence. However, patients r
Autor:
Julia E. McGuinness, Tarsha Jones, Elana Levinson, Donna Russo, Wendy K. Chung, Carrie Koval, Ilana Chilton, Meghna S. Trivedi, Boya Guo, Roshni Rao
Publikováno v:
Cancer Research. 80:P6-08
Background: Contralateral prophylactic mastectomy (CPM) is a risk-reducing surgery offered to women with unilateral breast cancer intended to reduce the risk of contralateral breast cancer. The rate of CPM among women with unilateral early-stage brea
Autor:
Thomas Silverman, Meghna S. Trivedi, Katherine D. Crew, Vicky Ro, Julia E. McGuinness, Wendy K. Chung, Rita Kukafka, Tarsha Jones
Publikováno v:
Cancer Research. 81:PS8-08
Introduction Current guidelines for cancer risk management for hereditary breast cancer focus on individuals with pathogenic/likely pathogenic variants (P/LP) in high penetrance genes. There is little consensus on prophylactic mastectomy for low/mode
Autor:
Hilary Colbeth, Jennifer Vargas, Julia E. McGuinness, Rita Kukafka, Alejandro Vanegas, Xinyi Li, Rossy Sandoval, Katherine D. Crew
Publikováno v:
Journal of Clinical Oncology. 35:e13044-e13044
e13044 Background: One of the barriers to chemoprevention uptake among high-risk women is the lack of routine breast cancer risk assessment in the primary care setting. We calculated breast cancer risk using the Breast Cancer Surveillance Consortium